FDA Approved: VIGABATRIN — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Vigabatrin (Par Health USA, LLC). This action approves changes to the product as requested by the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)